Role of fibrin structure in thrombosis and vascular disease

Advances in Protein Chemistry and Structural Biology

Volumn 83, Issue , 2011, Pages 75-127

  La Corte, Amy L Cilia ^a   Philippou, Helen ^a   Arins, Robert A S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Factor XIII; Fibrin structure; Fibrinogen; Fibrinolysis; Thrombosis

Indexed keywords

EID: 79956107816     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381262-9.00003-3     Document Type: Chapter

References (265)

1. R.H. Abou-Saleh, S.D. Connell, R. Harrand, R.A. Ajjan, M.W. Mosesson, and D.A. Smith Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers Biophys. J. 96 2009 2415 2427
2. S.S. Acharya, and D.M. Dimichele Rare inherited disorders of fibrinogen Haemophilia 14 2008 1151 1158
3. R. Ajjan, B.C. Lim, K.F. Standeven, R. Harrand, S. Dolling, and F. Phoenix Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity Blood 111 2008 643 650
4. R. Ajjan, R.F. Storey, and P.J. Grant Aspirin resistance and diabetes mellitus Diabetologia 51 2008 385 390
5. A. Antovic, C. Perneby, G.J. Ekman, H.N. Wallen, P. Hjemdahl, and M. Blomback Marked increase of fibrin gel permeability with very low dose ASA treatment Thromb. Res. 116 2005 509 517 (Pubitemid 41330816)
6. R.A. Arins, T.S. Lai, J.W. Weisel, C.S. Greenberg, and P.J. Grant Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms Blood 100 2002 743 754 (Pubitemid 34832596)
7. R.A. Arins, H. Philippou, C. Nagaswami, J.W. Weisel, D.A. Lane, and P.J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 2000 988 995 (Pubitemid 30616865)
8. M.A. Arnaout Integrin structure: new twists and turns in dynamic cell adhesion Immunol. Rev. 186 2002 125 140
9. R. Asselta, S. Duga, and M.L. Tenchini The molecular basis of quantitative fibrinogen disorders J. Thromb. Haemost. 4 2006 2115 2129 (Pubitemid 44400283)
10. L.E. Averett, B.B. Akhremitchev, M.H. Schoenfisch, and O.V. Gorkun Calcium dependence of fibrin nanomechanics: the gamma1 calcium mediates the unfolding of fibrinogen induced by force applied to the "Aa" bond Langmuir 26 2010 14716 14722
11. M.S. Bajaj, M.N. Kuppuswamy, H. Saito, S.G. Spitzer, and S.P. Bajaj Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis Proc. Natl. Acad. Sci. USA 87 1990 8869 8873 (Pubitemid 120007610)
12. L. Bajzar, J. Morser, and M. Nesheim TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombinthrombomodulin complex J. Biol. Chem. 271 1996 16603 16608 (Pubitemid 26239017)
13. M.D. Bale, L.G. Westrick, and D.F. Mosher Incorporation of thrombospondin into fibrin clots J. Biol. Chem. 260 1985 7502 7508 (Pubitemid 15063028)
14. E.L. Barry, and D.F. Mosher Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments J. Biol. Chem. 264 1989 4179 4185 (Pubitemid 19072314)
15. R.E. Baumann, and A.H. Henschen Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions A alpha 312 and B beta 448 Blood 82 1993 2117 2124 (Pubitemid 23293995)
16. I. Behague, O. Poirier, V. Nicaud, A. Evans, D. Arveiler, and G. Luc Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde Circulation 93 1996 440 449 (Pubitemid 26043602)
17. A.M. Belkin, G. Tsurupa, E. Zemskov, Y. Veklich, J.W. Weisel, and L. Medved Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling Blood 105 2005 3561 3568 (Pubitemid 40628201)
18. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, and H. de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67 (Pubitemid 24144355)
19. N. Bhasin, R.A. Arins, R.M. West, D.J. Parry, P.J. Grant, and D.J. Scott Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication J. Vasc. Surg. 48 2008 1497 1503
20. C.G. Binnie, and S.T. Lord The fibrinogen sequences that interact with thrombin Blood 81 1993 3186 3192 (Pubitemid 23172897)
21. T.D. Bjornsson, D.E. Schneider, and H. Berger Jr. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels J. Pharmacol. Exp. Ther. 250 1989 154 161 (Pubitemid 19194985)
22. B. Blombck Fibrinogen and fibrinproteins with complex roles in hemostasis and thrombosis Thromb. Res. 83 1996 1 75
23. B. Blombck, K. Carlsson, K. Fatah, B. Hessel, and R. Procyk Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation Thromb. Res. 75 1994 521 538 (Pubitemid 24267336)
24. R.E. Bottenus, A. Ichinose, and E.W. Davie Nucleotide sequence of the gene for the b subunit of human factor XIII Biochemistry 29 1990 11195 11209
25. E.P. Brass, W.B. Forman, R.V. Edwards, and O. Lindan Fibrin formation: effect of calcium ions Blood 52 1978 654 658 (Pubitemid 9032635)
26. A.W. Broekmans, J.J. Veltkamp, and R.M. Bertina Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families N. Engl. J. Med. 309 1983 340 344
27. A.E. Brown, R.I. Litvinov, D.E. Discher, P.K. Purohit, and J.W. Weisel Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water Science 325 2009 741 744
28. J.H. Brown, N. Volkmann, G. Jun, A.H. Henschen-Edman, and C. Cohen The crystal structure of modified bovine fibrinogen Proc. Natl. Acad. Sci. USA 97 2000 85 90 (Pubitemid 30055788)
29. G.J. Broze Jr. Tissue factor pathway inhibitor and the revised theory of coagulation Annu. Rev. Med. 46 1995 103 112
30. G.J. Broze Jr., T.J. Girard, and W.F. Novotny Regulation of coagulation by a multivalent Kunitz-type inhibitor Biochemistry 29 1990 7539 7546 (Pubitemid 20279168)
31. R.A. Burton, G. Tsurupa, R.R. Hantgan, N. Tjandra, and L. Medved NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment Biochemistry 46 2007 8550 8560 (Pubitemid 47106106)
32. R.A. Burton, G. Tsurupa, L. Medved, and N. Tjandra Identification of an ordered compact structure within the recombinant bovine fibrinogen alphaC-domain fragment by NMR Biochemistry 45 2006 2257 2266 (Pubitemid 43271325)
33. C.R. Carlisle, E.A. Sparks, L.C. Der, and M. Guthold Strength and failure of fibrin fiber branchpoints J. Thromb. Haemost. 8 2010 1135 1138
34. A.M. Carter, A.J. Catto, J.M. Bamford, and P.J. Grant Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease Arterioscler. Thromb. Vasc. Biol. 17 1997 589 594 (Pubitemid 27133152)
35. A.M. Carter, A.J. Catto, and P.J. Grant Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation Circulation 99 1999 2423 2426 (Pubitemid 29218238)
36. A.M. Carter, A.J. Catto, H.P. Kohler, R.A. Arins, M.H. Stickland, and P.J. Grant Alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism Blood 96 2000 1177 1179 (Pubitemid 30616891)
37. A.M. Carter, M.W. Mansfield, M.H. Stickland, and P.J. Grant Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM Diabetes Care. 19 1996 1265 1268
38. A.M. Carter, N. Ossei-Gerning, I.J. Wilson, and P.J. Grant Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease Circulation 96 1997 1424 1431 (Pubitemid 27375332)
39. F.A. Carvalho, S. Connell, G. Miltenberger-Miltenyi, S.V. Pereira, A. Tavares, and R.A. Arins Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes ACS Nano 4 2010 4609 4620
40. E.A. Caspary Studies on the acetylation of human fibrinogen Biochem. J. 62 1956 507 512
41. A.J. Catto, H.P. Kohler, S. Bannan, M. Stickland, A. Carter, and P.J. Grant Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage Stroke 29 1998 813 816 (Pubitemid 28173407)
42. A.J. Catto, H.P. Kohler, J. Coore, M.W. Mansfield, M.H. Stickland, and P.J. Grant Association of a common polymorphism in the factor XIII gene with venous thrombosis Blood 93 1999 906 908 (Pubitemid 29067855)
43. I.F. Charo, L.S. Bekeart, and D.R. Phillips Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix J. Biol. Chem. 262 1987 9935 9938 (Pubitemid 17103055)
44. R. Chen, and R.F. Doolittle Gammagamma cross-linking sites in human and bovine fibrin Biochemistry 10 1971 4487 4491
45. D.A. Cheresh Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor Proc. Natl. Acad. Sci. USA 84 1987 6471 6475 (Pubitemid 18002812)
46. D.A. Cheresh, S.A. Berliner, V. Vicente, and Z.M. Ruggeri Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells Cell 58 1989 945 953 (Pubitemid 19227902)
47. E.Y. Cheung, d.W. Uitte, H.L. Vos, F.W. Leebeek, D.W. Dippel, and R.M. Bertina Fibrinogen gamma' in ischemic stroke: a casecontrol study Stroke 39 2008 1033 1035 (Pubitemid 351619556)
48. D. Collen Natural inhibitors of fibrinolysis J. Clin. Pathol. Suppl. (R. Coll. Pathol.) 1980 24 30
49. D. Collen The plasminogen (fibrinolytic) system Thromb. Haemost. 82 1999 259 270
50. J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, and A. Ankri Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis Arterioscler. Thromb. Vasc. Biol. 26 2006 2567 2573 (Pubitemid 44607482)
51. J.P. Collet, C. Lesty, G. Montalescot, and J.W. Weisel Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots J. Biol. Chem. 278 2003 21331 21335 (Pubitemid 36792527)
52. J.P. Collet, J.L. Moen, Y.I. Veklich, O.V. Gorkun, S.T. Lord, and G. Montalescot The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis Blood 106 2005 3824 3830 (Pubitemid 41739019)
53. J.P. Collet, D. Park, C. Lesty, J. Soria, C. Soria, and G. Montalescot Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy Arterioscler. Thromb. Vasc. Biol. 20 2000 1354 1361 (Pubitemid 30262939)
54. J.P. Collet, H. Shuman, R.E. Ledger, S. Lee, and J.W. Weisel The elasticity of an individual fibrin fiber in a clot Proc. Natl. Acad. Sci. USA 102 2005 9133 9137 (Pubitemid 40923529)
55. P.C. Comp, and C.T. Esmon Activated protein C inhibits platelet prothrombin-converting activity Blood 54 1979 1272 1281 (Pubitemid 10212768)
56. A.V. Cooper, K.F. Standeven, and R.A. Ariens Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure Blood 102 2003 535 540 (Pubitemid 36841972)
57. B.A. Cottrell, D.D. Strong, K.W. Watt, and R.F. Doolittle Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites Biochemistry 18 1979 5405 5410 (Pubitemid 10140282)
58. R.B. Credo, C.G. Curtis, and L. Lorand Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects Biochemistry 20 1981 3770 3778 (Pubitemid 11009220)
59. C.G. Curtis, K.L. Brown, R.B. Credo, R.A. Domanik, A. Gray, and P. Stenberg Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor Biochemistry 13 1974 3774 3780
60. B. Dahlback Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene Haemostasis 24 1994 139 151 (Pubitemid 24234492)
61. B. Dahlback, M. Carlsson, and P.J. Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc. Natl. Acad. Sci. USA 90 1993 1004 1008 (Pubitemid 23053939)
62. B. Dahlback, and J. Stenflo Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa Eur. J. Biochem. 107 1980 331 335 (Pubitemid 11246067)
63. P.S. Damus, M. Hicks, and R.D. Rosenberg Anticoagulant action of heparin Nature 246 1973 355 357
64. C.V. Dang, C.K. Shin, W.R. Bell, C. Nagaswami, and J.W. Weisel Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly J. Biol. Chem. 264 1989 15104 15108 (Pubitemid 19237344)
65. K. Danielyan, K. Ganguly, B.S. Ding, D. Atochin, S. Zaitsev, and J.C. Murciano Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator Circulation 118 2008 1442 1449
66. M.M. Denis, N.D. Tolley, M. Bunting, H. Schwertz, H. Jiang, and S. Lindemann Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets Cell 122 2005 379 391 (Pubitemid 41127140)
67. R.F. Doolittle Fibrinogen and fibrin A. Bloom, v Forbes, D. Thomas, E Tuddenham, Haemostasis and Thrombosis 1994 Churchill Livingston Edinburgh 491 513
68. R.F. Doolittle, D.M. Goldbaum, and L.R. Doolittle Designation of sequences involved in the "coiled-coil" interdominal connections in fibrinogen: constructions of an atomic scale model J. Mol. Biol. 120 1978 311 325 (Pubitemid 8314290)
69. A.F. Drew, H. Liu, J.M. Davidson, C.C. Daugherty, and J.L. Degen Wound-healing defects in mice lacking fibrinogen Blood 97 2001 3691 3698
70. E.J. Dunn, R.A. Arins, and P.J. Grant The influence of type 2 diabetes on fibrin structure and function Diabetologia 48 2005 1198 1206 (Pubitemid 40909657)
71. E.J. Dunn, H. Philippou, R.A. Arins, and P.J. Grant Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus Diabetologia 49 2006 1071 1080
72. C.T. Esmon Protein-C: biochemistry, physiology, and clinical implications Blood 62 1983 1155 1158 (Pubitemid 14209659)
73. D.H. Farrell, and P. Thiagarajan Binding of recombinant fibrinogen mutants to platelets J. Biol. Chem. 269 1994 226 231 (Pubitemid 24026648)
74. K. Fatah, H. Beving, A. Albage, T. Ivert, and M. Blomback Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur. Heart J. 17 1996 1362 1366 (Pubitemid 26306664)
75. K. Fatah, A. Hamsten, B. Blomback, and M. Blomback Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis Thromb. Haemost. 68 1992 130 135
76. K. Fatah, A. Silveira, P. Tornvall, F. Karpe, M. Blomback, and A. Hamsten Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age Thromb. Haemost. 76 1996 535 540 (Pubitemid 26372007)
77. W.P. Fay, D.T. Eitzman, A.D. Shapiro, E.L. Madison, and D. Ginsburg Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms Blood 83 1994 351 356 (Pubitemid 24030558)
78. J.D. Ferry The mechanism of polymerization of fibrinogen Proc. Natl. Acad. Sci. USA 38 1952 566 569
79. J.E. Folk Mechanism and basis for specificity of transglutaminase- catalyzed epsilon-(gamma-glutamyl) lysine bond formation Adv. Enzymol. Relat. Areas Mol. Biol. 54 1983 1 56
80. C.W. Francis, V.J. Marder, and S.E. Martin Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes Blood 56 1980 456 464 (Pubitemid 11251027)
81. C.W. Francis, R.L. Nachman, and V.J. Marder Plasma and platelet fibrinogen differ in gamma chain content Thromb. Haemost. 51 1984 84 88 (Pubitemid 14159208)
82. R.F. Franco, P.H. Reitsma, D. Lourenco, F.H. Maffei, V. Morelli, and M.H. Tavella Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis Thromb. Haemost. 81 1999 676 679 (Pubitemid 29216548)
83. L.J. Fretto, E.W. Ferguson, H.M. Steinman, and P.A. McKee Localization of the alpha-chain cross-link acceptor sites of human fibrin J. Biol. Chem. 253 1978 2184 2195 (Pubitemid 8328200)
84. Y. Fu, and G. Grieninger Fib420: a normal human variant of fibrinogen with two extended alpha chains Proc. Natl. Acad. Sci. USA 91 1994 2625 2628
85. Y. Fu, L. Weissbach, P.W. Plant, C. Oddoux, Y. Cao, and T.J. Liang Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits Biochemistry 31 1992 11968 11972 (Pubitemid 23011337)
86. Y. Fu, J.Z. Zhang, C.M. Redman, and G. Grieninger Formation of the human fibrinogen subclass fib420: disulfide bonds and glycosylation in its unique (alphaE chain) domains Blood 92 1998 3302 3308 (Pubitemid 28492338)
87. V. Fuster, P.R. Moreno, Z.A. Fayad, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part I: evolving concepts J. Am. Coll. Cardiol. 46 2005 937 954 (Pubitemid 41316498)
88. P.J. Gaffney, and A.N. Whitaker Fibrin crosslinks and lysis rates Thromb. Res. 14 1979 85 94 (Pubitemid 9108083)
89. K.C. Gersh, and S.T. Lord An investigation of Factor XIII binding to recombinant gamma'/gamma' and gamma/gamma' fibrinogen Blood 108 2006 1705
90. K.C. Gersh, C. Nagaswami, and J.W. Weisel Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes Thromb. Haemost. 102 2009 1169 1175
91. K.C. Gersh, C. Nagaswami, J.W. Weisel, and S.T. Lord The presence of gamma' chain impairs fibrin polymerization Thromb. Res. 124 2009 356 363
92. T.J. Girard, L.A. Warren, W.F. Novotny, K.M. Likert, S.G. Brown, and J.P. Miletich Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor Nature 338 1989 518 520 (Pubitemid 19107996)
93. O.V. Gorkun, Y.I. Veklich, L.V. Medved, A.H. Henschen, and J.W. Weisel Role of the alpha C domains of fibrin in clot formation Biochemistry 33 1994 6986 6997
94. J.J. Gorman, and J.E. Folk Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides J. Biol. Chem. 256 1981 2712 2715
95. P.E. Greilich, M.E. Carr, S.L. Zekert, and R.M. Dent Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease Am. J. Med. Sci. 307 1994 15 20
96. J.H. Griffin, B. Evatt, T.S. Zimmerman, A.J. Kleiss, and C. Wideman Deficiency of protein C in congenital thrombotic disease J. Clin. Invest. 68 1981 1370 1373 (Pubitemid 12235040)
97. M. Guthold, and C. Carlisle Single fibrin fiber experiments suggest longitudinal rather than transverse crosslinking 2010 J. Thromb Haemost
98. T.M. Hackeng, K.M. Sere, G. Tans, and J. Rosing Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor Proc. Natl. Acad. Sci. USA 103 2006 3106 3111 (Pubitemid 43346432)
99. M. Hada, M. Kaminski, P. Bockenstedt, and J. McDonagh Covalent crosslinking of von Willebrand factor to fibrin Blood 68 1986 95 101 (Pubitemid 16033620)
100. C.E. Hall, and H.S. Slayter The fibrinogen molecule: its size, shape, and mode of polymerization J. Biophys. Biochem. Cytol. 5 1959 11 16
101. K.W. Harris, and C.T. Esmon Protein S is required for bovine platelets to support activated protein C binding and activity J. Biol. Chem. 260 1985 2007 2010 (Pubitemid 15112049)
102. S. He, N. Bark, H. Wang, J. Svensson, and M. Blomback Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis J. Cardiovasc. Pharmacol. 53 2009 24 29
103. R.F. Highsmith, and R.D. Rosenberg The inhibition of human plasmin by human antithrombin-heparin cofactor J. Biol. Chem. 249 1974 4335 4338
104. M.H. Horellou, J. Conard, R.M. Bertina, and M. Samama Congenital protein C deficiency and thrombotic disease in nine French families Br. Med. J. Clin. Res. Ed. 289 1984 1285 1287 (Pubitemid 15217617)
105. L. Hsieh, and D. Nugent Factor XIII deficiency Haemophilia 14 2008 1190 1200
106. S.E. Humphries, M. Cook, M. Dubowitz, Y. Stirling, and T.W. Meade Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations Lancet 1 1987 1452 1455
107. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpinprotease complex shows inhibition by deformation Nature 407 2000 923 926
108. 2+ mediates strong and specific interaction of single-chain urokinase with fibrin J. Biol. Chem. 268 1993 8574 8579 (Pubitemid 23118639)
109. A. Ichinose, and E.W. Davie Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor Proc. Natl. Acad. Sci. USA 85 1988 5829 5833
110. A. Ichinose, B.A. McMullen, K. Fujikawa, and E.W. Davie Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments Biochemistry 25 1986 4633 4638 (Pubitemid 16010198)
111. H. Iwata, T. Kitano, K. Umetsu, I. Yuasa, K. Yamazaki, and B. Kemkes-Matthes Distinct C-terminus of the B subunit of factor XIII in a population-associated major phenotype: the first case of complete allele-specific alternative splicing products in the coagulation and fibrinolytic systems J. Thromb. Haemost. 7 2009 1084 1091
112. T.J. Janus, S.D. Lewis, L. Lorand, and J.A. Shafer Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen Biochemistry 22 1983 6269 6272 (Pubitemid 14175823)
113. E.L. Kaijzel, P. Koolwijk, M.G. van Erck, V.W. van Hinsbergh, and M.P. de Maat Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo J. Thromb. Haemost. 4 2006 1975 1981 (Pubitemid 44226777)
114. T. Kamata, A. Irie, M. Tokuhira, and Y. Takada Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3) J. Biol. Chem. 271 1996 18610 18615 (Pubitemid 26322724)
115. M.I. Kamboh, and R.E. Ferrell Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB Am. J. Hum. Genet. 39 1986 817 825 (Pubitemid 17014496)
116. H. Kang, Q. Wen, P.A. Janmey, J.X. Tang, E. Conti, and F.C. MacKintosh Nonlinear elasticity of stiff filament networks: strain stiffening, negative normal stress, and filament alignment in fibrin gels J. Phys. Chem. B 113 2009 3799 3805
117. J.A. Kant, A.J. Fornace Jr., D. Saxe, M.I. Simon, O.W. McBride, and G.R. Crabtree Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion Proc. Natl. Acad. Sci. USA 82 1985 2344 2348 (Pubitemid 15064484)
118. S. Kimura, and N. Aoki Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor J. Biol. Chem. 261 1986 15591 15595 (Pubitemid 17208788)
119. M. Kloczewiak, S. Timmons, T.J. Lukas, and J. Hawiger Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain Biochemistry 23 1984 1767 1774 (Pubitemid 14139817)
120. H.P. Kohler, T.S. Futers, and P.J. Grant Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease Thromb. Haemost. 81 1999 511 515 (Pubitemid 29178932)
121. H.P. Kohler, and P.J. Grant Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarction Thromb. Haemost. 80 1998 862 (Pubitemid 28521738)
122. H.P. Kohler, M.H. Stickland, N. Ossei-Gerning, A. Carter, H. Mikkola, and P.J. Grant Association of a common polymorphism in the factor XIII gene with myocardial infarction Thromb. Haemost. 79 1998 8 13 (Pubitemid 28037047)
123. J.M. Kollman, L. Pandi, M.R. Sawaya, M. Riley, and R.F. Doolittle Crystal structure of human fibrinogen Biochemistry 48 2009 3877 3886
124. N. Komanasin, A.J. Catto, T.S. Futers, A. van Hylckama Vlieg, F.R. Rosendaal, and R.A. Ariens A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis J. Thromb. Haemost. 3 2005 2487 2496 (Pubitemid 41727166)
125. T. Koster, F.R. Rosendaal, H. de Ronde, E. Brit, J.P. Vandenbroucke, and R.M. Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Lancet 342 1993 1503 1506 (Pubitemid 23362165)
126. S. Lancellotti, S. Rutella, V. De Filippis, N. Pozzi, B. Rocca, and R. De Cristofaro Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors J. Biol. Chem. 283 2008 30193 30204
127. D.A. Lane, and R. Caso Antithrombin: structure, genomic organization, function and inherited deficiency Baillires Clin. Haematol. 2 1989 961 998 (Pubitemid 19282001)
128. B.G. Langer, J.W. Weisel, P.A. Dinauer, C. Nagaswami, and W.R. Bell Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers J. Biol. Chem. 263 1988 15056 15063
129. N. Laurens, M.A. Engelse, C. Jungerius, C.W. Lowik, V.W. van Hinsbergh, and P. Koolwijk Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix Angiogenesis 12 2009 275 285
130. N. Laurens, P. Koolwijk, and M.P. de Maat Fibrin structure and wound healing J. Thromb. Haemost. 4 2006 932 939
131. A.M. Lauricella, I.L. Quintana, and L.C. Kordich Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm Thromb. Res. 107 2002 75 79 (Pubitemid 35284429)
132. K.N. Lee, K.W. Jackson, V.J. Christiansen, K.H. Chung, and P.A. McKee A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion Blood 103 2004 3783 3788 (Pubitemid 38596296)
133. K.N. Lee, K.W. Jackson, V.J. Christiansen, C.S. Lee, J.G. Chun, and P.A. McKee Why alpha-antiplasmin must be converted to a derivative form for optimal function J. Thromb. Haemost. 5 2007 2095 2104 (Pubitemid 47450029)
134. B.C. Lim, R.A. Arins, A.M. Carter, J.W. Weisel, and P.J. Grant Genetic regulation of fibrin structure and function: complex geneenvironment interactions may modulate vascular risk Lancet 361 2003 1424 1431 (Pubitemid 36515043)
135. B.B. Lim, E.H. Lee, M. Sotomayor, and K. Schulten Molecular basis of fibrin clot elasticity Structure 16 2008 449 459
136. W. Liu, C.R. Carlisle, E.A. Sparks, and M. Guthold The mechanical properties of single fibrin fibers J. Thromb. Haemost. 8 2010 1030 1036
137. W. Liu, L.M. Jawerth, E.A. Sparks, M.R. Falvo, R.R. Hantgan, and R. Superfine Fibrin fibers have extraordinary extensibility and elasticity Science 313 2006 634 (Pubitemid 44201134)
138. P.J. Loll, D. Picot, and R.M. Garavito The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase Nat. Struct. Biol. 2 1995 637 643
139. L. Lorand, J. Downey, T. Gotoh, A. Jacobsen, and S. Tokura The transpeptidase system which crosslinks fibrin by gamma-glutamyle-episilon-lysine bonds Biochem. Biophys. Res. Commun. 31 1968 222 230
140. L. Lorand, K.N. Parameswaran, and S.N. Murthy A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa Proc. Natl. Acad. Sci. USA 95 1998 537 541
141. R.S. Lovely, L.A. Falls, H.A. Al Mondhiry, C.E. Chambers, G.J. Sexton, and H. Ni Association of gammaA/gamma' fibrinogen levels and coronary artery disease Thromb. Haemost. 88 2002 26 31 (Pubitemid 34752262)
142. R.S. Lovely, C.M. Rein, T.C. White, S.A. Jouihan, L.K. Boshkov, and A.C. Bakke GammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation Thromb. Haemost. 100 2008 837 846
143. B. Ly, and H.C. Godal Denaturation of fibrinogen: the protective effect of calcium Haemostasis 1 1973 204 209
144. J. Madrazo, J.H. Brown, S. Litvinovich, R. Dominguez, S. Yakovlev, and L. Medved Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-A resolution Proc. Natl. Acad. Sci. USA 98 2001 11967 11972 (Pubitemid 32959810)
145. M.N. Mannila, R.S. Lovely, S.C. Kazmierczak, P. Eriksson, A. Samnegard, and D.H. Farrell Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors J. Thromb. Haemost. 5 2007 766 773 (Pubitemid 46563576)
146. J.A. Marcum, J.B. McKenney, S.J. Galli, R.W. Jackman, and R.D. Rosenberg Anticoagulantly active heparin-like molecules from mast cell-deficient mice Am. J. Physiol. 250 1986 H879 H888
147. J.A. Marcum, and R.D. Rosenberg Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells Biochem. Biophys. Res. Commun. 126 1985 365 372 (Pubitemid 15173570)
148. J. Martinez, P.M. Keane, P.B. Gilman, and J.E. Palascak The abnormal carbohydrate composition of the dysfibrinogenemia associated with liver disease Ann. NY Acad. Sci. 408 1983 388 396 (Pubitemid 13072051)
149. J. Martinez, K.A. MacDonald, and J.E. Palascak The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains Blood 61 1983 1196 1202 (Pubitemid 13099909)
150. Y.V. Matsuka, L.V. Medved, M.M. Migliorini, and K.C. Ingham Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen Biochemistry 35 1996 5810 5816 (Pubitemid 26143676)
151. S. Metassan, A.J. Charlton, M.N. Routledge, D.J. Scott, and R.A. Arins Alteration of fibrin clot properties by ultrafine particulate matter Thromb. Haemost. 103 2010 103 113
152. S. Metassan, M.N. Routledge, A.J. Lucking, S.U. de Willige, H. Philippou, and N.L. Mills Fibrin clot structure remains unaffected in young, healthy individuals after transient exposure to diesel exhaust Part Fibre. Toxicol. 7 2010 17
153. H. Mikkola, M. Syrjala, V. Rasi, E. Vahtera, E. Hamalainen, and L. Peltonen Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels Blood 84 1994 517 525 (Pubitemid 24215952)
154. K.A. Miller, D.S. Siscovick, L. Sheppard, K. Shepherd, J.H. Sullivan, and G.L. Anderson Long-term exposure to air pollution and incidence of cardiovascular events in women N. Engl. J. Med. 356 2007 447 458 (Pubitemid 46193072)
155. J.D. Mills, R.A. Arins, M.W. Mansfield, and P.J. Grant Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease Circulation 106 2002 1938 1942 (Pubitemid 35176298)
156. M.W. Mosesson, J.P. DiOrio, I. Hernandez, J.F. Hainfeld, J.S. Wall, and G. Grieninger The ultrastructure of fibrinogen-420 and the fibrin-420 clot Biophys. Chem. 112 2004 209 214 (Pubitemid 39574420)
157. M.W. Mosesson, and J.S. Finlayson Biochemical and chromatographic studies of certain activities associated with human fibrinogen preparations J. Clin. Invest. 42 1963 747 755
158. M.W. Mosesson, and J.S. Finlayson Subfractions of human fibrinogen; preparation and analysis J. Lab. Clin. Med. 62 1963 663 674
159. M.W. Mosesson, I. Hernandez, T.J. Raife, L. Medved, S. Yakovlev, and P.J. Simpson-Haidaris Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome J. Thromb. Haemost. 5 2007 62 69 (Pubitemid 44921068)
160. M.W. Mosesson, G.A. Homandberg, and D.L. Amrani Human platelet fibrinogen gamma chain structure Blood 63 1984 990 995 (Pubitemid 14100896)
161. M.W. Mosesson, K.R. Siebenlist, J.P. DiOrio, M. Matsuda, J.F. Hainfeld, and J.S. Wall The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg>Cys) J. Clin. Invest. 96 1995 1053 1058
162. M.W. Mosesson, K.R. Siebenlist, and D.A. Meh The structure and biological features of fibrinogen and fibrin Ann. NY Acad. Sci. 936 2001 11 30 (Pubitemid 32613890)
163. D.F. Mosher, and P.E. Schad Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa J. Clin. Invest. 64 1979 781 787 (Pubitemid 10223757)
164. L. Muszbek, R. Adany, and H. Mikkola Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function Crit. Rev. Clin. Lab. Sci. 33 1996 357 421 (Pubitemid 26405375)
165. L. Muszbek, R.A. Arins, and A. Ichinose Factor XIII: recommended terms and abbreviations J. Thromb. Haemost. 5 2007 181 183 (Pubitemid 44921084)
166. L. Muszbek, Z. Bagoly, Z. Bereczky, and E. Katona The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis Cardiovasc. Hematol. Agents Med. Chem. 6 2008 190 205
167. M. Ndonwi, E.A. Tuley, and G.J. Broze Jr. The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition Blood 116 2010 1344 1351
168. M. Nesheim Thrombin and fibrinolysis Chest 124 2003 33S 39S (Pubitemid 37128434)
169. M. Nesheim, W. Wang, M. Boffa, M. Nagashima, J. Morser, and L. Bajzar Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis Thromb. Haemost. 78 1997 386 391 (Pubitemid 27289272)
170. T.M. Odrljin, B.J. Rybarczyk, C.W. Francis, S.O. Lawrence, M. Hamaguchi, and P.J. Simpson-Haidaris Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain Biochim. Biophys. Acta 1298 1996 69 77 (Pubitemid 26390920)
171. B. Osterud, and S.I. Rapaport Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation Proc. Natl. Acad. Sci. USA 74 1977 5260 5264
172. I. Pechik, J. Madrazo, M.W. Mosesson, I. Hernandez, G.L. Gilliland, and L. Medved Crystal structure of the complex between thrombin and the central "E" region of fibrin Proc. Natl. Acad. Sci. USA 101 2004 2718 2723 (Pubitemid 38327677)
173. E.I. Peerschke, C.W. Francis, and V.J. Marder Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length Blood 67 1986 385 390 (Pubitemid 16164653)
174. A. Peters, S. von Klot, M. Heier, I. Trentinaglia, A. Hormann, and H.E. Wichmann Exposure to traffic and the onset of myocardial infarction N. Engl. J. Med. 351 2004 1721 1730 (Pubitemid 39383207)
175. M. Pieters, N. Covic, F.H. van der Westhuizen, C. Nagaswami, Y. Baras, and L.D. Toit Glycaemic control improves fibrin network characteristics in type 2 diabetesa purified fibrinogen model Thromb. Haemost. 99 2008 691 700 (Pubitemid 351694225)
176. C.A. Pope III, R.T. Burnett, G.D. Thurston, M.J. Thun, E.E. Calle, and D. Krewski Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease Circulation 109 2004 71 77 (Pubitemid 38056024)
177. C.A. Pope III, J.B. Muhlestein, H.T. May, D.G. Renlund, J.L. Anderson, and B.D. Horne Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution Circulation 114 2006 2443 2448 (Pubitemid 44901516)
178. C.H. Pospisil, A.R. Stafford, J.C. Fredenburgh, and J.I. Weitz Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin J. Biol. Chem. 278 2003 21584 21591 (Pubitemid 36792557)
179. K.P. Pratt, H.C. Cote, D.W. Chung, R.E. Stenkamp, and E.W. Davie The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro Proc. Natl. Acad. Sci. USA 94 1997 7176 7181
180. R. Procyk, and B. Blomback Disulfide bond reduction in fibrinogen: calcium protection and effect on clottability Biochemistry 29 1990 1501 1507 (Pubitemid 20063381)
181. D.M. Pruissen, A.J. Slooter, F.R. Rosendaal, Y. van der Graaf, and A. Algra Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke Blood 111 3 2008 1282 1286 (Pubitemid 351213411)
182. L.V. Rao, O. Nordfang, A.D. Hoang, and U.R. Pendurthi Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity Blood 85 1995 121 129
183. L.V. Rao, S.I. Rapaport, and A.D. Hoang Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa Blood 81 1993 2600 2607 (Pubitemid 23147563)
184. J.C. Rau, L.M. Beaulieu, J.A. Huntington, and F.C. Church Serpins in thrombosis, hemostasis and fibrinolysis J. Thromb. Haemost. 5 Suppl 1 2007 102 115 (Pubitemid 46958823)
185. A. Redlitz, A.K. Tan, D.L. Eaton, and E.F. Plow Plasma carboxypeptidases as regulators of the plasminogen system J. Clin. Invest. 96 1995 2534 2538
186. A.P. Reiner, M.B. Frank, S.M. Schwartz, M.L. Linenberger, W.T. Longstreth, G. Teramura, F.R. Rosendaal, B.M. Psaty, and D.S. Siscovick Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women Br. J. Haematol. 116 2 2002 376 382 (Pubitemid 34155511)
187. J.A. Remijn, R. van Wijk, P.G. de Groot, and W.W. van Solinge Nature of the fibrinogen Aα gene TaqI polymorphism Thromb. Haemost. 86 3 2001 935 936 (Pubitemid 32834212)
188. M. Rendell, J. Nierenberg, C. Brannan, J.L. Valentine, P.M. Stephen, and S. Dodds Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo J. Lab. Clin. Med. 108 1986 286 293 (Pubitemid 16003234)
189. D.C. Rijken, and D.V. Sakharov Basic principles in thrombolysis: regulatory role of plasminogen Thromb. Res. 103 Suppl 1 2001 S41 S49
190. A.M. Rojas, L. Kordich, and A.M. Lauricella Homocysteine modifies fibrin clot deformability: another possible explanation of harm Biorheology 46 2009 379 387
191. J.S. Rosenberg, P.W. McKenna, and R.D. Rosenberg Inhibition of human factor IXa by human antithrombin J. Biol. Chem. 250 1975 8883 8888
192. G.J. Roth, N. Stanford, and P.W. Majerus Acetylation of prostaglandin synthase by aspirin Proc. Natl. Acad. Sci. USA 72 1975 3073 3076
193. Y.M. Ruigrok, A.J. Slooter, G.J. Rinkel, C. Wijmenga, and F.R. Rosendaal Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding Acta Neurochir. (Wien.) 152 2010 257 262
194. A.W. Ryan, D.A. Hughes, K. Tang, D.P. Kelleher, T. Ryan, and R. McManus Natural selection and the molecular basis of electrophoretic variation at the coagulation F13B locus Eur. J. Hum. Genet. 17 2009 219 227
195. Y. Sakata, and N. Aoki Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis J. Clin. Invest. 69 1982 536 542 (Pubitemid 12184949)
196. P.M. Sandset Tissue factor pathway inhibitor (TFPI)an update Haemostasis 26 Suppl 4 1996 154 165 (Pubitemid 26417433)
197. D.C. Sane, T.L. Moser, A.M. Pippen, C.J. Parker, K.E. Achyuthan, and C.S. Greenberg Vitronectin is a substrate for transglutaminases Biochem. Biophys. Res. Commun. 157 1988 115 120 (Pubitemid 19004833)
198. D.L. Sauls, E. Lockhart, M.E. Warren, A. Lenkowski, S.E. Wilhelm, and M. Hoffman Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia Biochemistry 45 2006 2480 2487
199. D.L. Sauls, A.S. Wolberg, and M. Hoffman Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia J. Thromb. Haemost. 1 2003 300 306
200. M.L. Schwartz, S.V. Pizzo, R.L. Hill, and P.A. McKee Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin J. Biol. Chem. 248 1973 1395 1407
201. H. Schwertz, N.D. Tolley, J.M. Foulks, M.M. Denis, B.W. Risenmay, and M. Buerke Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets J. Exp. Med. 203 2006 2433 2440 (Pubitemid 44664613)
202. E.M. Scott, R.A. Arins, and P.J. Grant Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease Arterioscler. Thromb. Vasc. Biol. 24 2004 1558 1566 (Pubitemid 39180877)
203. B.H. Shilton, and D.J. Walton Sites of glycation of human and horse liver alcohol dehydrogenase in vivo J. Biol. Chem. 266 1991 5587 5592 (Pubitemid 21909534)
204. A. Shimizu, G.M. Nagel, and R.F. Doolittle Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to gamma-chain residues 337379 Proc. Natl. Acad. Sci. USA 89 1992 2888 2892
205. K.R. Siebenlist, D.A. Meh, and M.W. Mosesson Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains Biochemistry 35 1996 10448 10453 (Pubitemid 26277304)
206. K.R. Siebenlist, and M.W. Mosesson Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen Biochemistry 35 1996 5817 5821 (Pubitemid 26143677)
207. K.R. Siebenlist, M.W. Mosesson, I. Hernandez, L.A. Bush, E. Di Cera, and J.R. Shainoff Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains Blood 106 2005 2730 2736 (Pubitemid 41510747)
208. J.H. Sobel, and M.A. Gawinowicz Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking J. Biol. Chem. 271 1996 19288 19297 (Pubitemid 26271597)
209. J. Soria, C. Soria, J.P. Collet, M. Mirishahi, H. Lu, and J.P. Caen Dysfibrinogenemia and thrombosis Nouv. Rev. Fr. Hmatol. 33 1991 457 459
210. G. Spraggon, S.J. Everse, and R.F. Doolittle Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin Nature 389 1997 455 462 (Pubitemid 27435313)
211. K.F. Standeven, A.M. Carter, P.J. Grant, J.W. Weisel, I. Chernysh, and L. Masova Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness Blood 110 2007 902 907 (Pubitemid 47267427)
212. K.F. Standeven, P.J. Grant, A.M. Carter, T. Scheiner, J.W. Weisel, and R.A. Arins Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function Circulation 107 2003 2326 2330 (Pubitemid 36578503)
213. N. Stead, A.P. Kaplan, and R.D. Rosenberg Inhibition of activated factor XII by antithrombin-heparin cofactor J. Biol. Chem. 251 1976 6481 6488
214. D.M. Stern, P.P. Nawroth, K. Harris, and C.T. Esmon Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va J. Biol. Chem. 261 1986 713 718 (Pubitemid 16161729)
215. D.C. Stump, H.R. Lijnen, and D. Collen Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures J. Biol. Chem. 261 1986 1274 1278 (Pubitemid 16103936)
216. K. Suehiro, J. Mizuguchi, K. Nishiyama, S. Iwanaga, D.H. Farrell, and S. Ohtaki Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain J. Biochem. 128 2000 705 710
217. K. Suzuki, J. Nishioka, M. Matsuda, H. Murayama, and S. Hashimoto Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va J. Biochem. 96 1984 455 460 (Pubitemid 14056117)
218. H. Tang, Y. Fu, S. Zhan, and Y. Luo Alpha(E)C, the C-terminal extension of fibrinogen, has chaperone-like activity Biochemistry 48 2009 3967 3976
219. S. Thorsen The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis Ann. NY Acad. Sci. 667 1992 52 63 (Pubitemid 23061563)
220. L. Tranqui, A. Andrieux, G. Hudry-Clergeon, J.J. Ryckewaert, S. Soyez, and A. Chapel Differential structural requirements for fibrinogen binding to platelets and to endothelial cells J. Cell Biol. 108 1989 2519 2527 (Pubitemid 19168940)
221. T.A. Trumbo, and M.C. Maurer Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation J. Biol. Chem. 275 2000 20627 20631 (Pubitemid 30457648)
222. T.A. Trumbo, and M.C. Maurer V34I and V34A substitutions within the factor XIII activation peptide segment (2841) affect interactions with the thrombin active site Thromb. Haemost. 89 2003 647 653 (Pubitemid 36456961)
223. G. Tsurupa, R.R. Hantgan, R.A. Burton, I. Pechik, N. Tjandra, and L. Medved Structure, stability, and interaction of the fibrin(ogen) alphaC-domains Biochemistry 48 2009 12191 12201
224. S. Uitte de Willige, M.C. De Visser, J.J. Houwing-Duistermaat, F.R. Rosendaal, H.L. Vos, and R.M. Bertina Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels Blood 106 2005 4176 4183 (Pubitemid 41775924)
225. S. Uitte de Willige, K.F. Standeven, H. Philippou, and R.A. Arins The pleiotropic role of the fibrinogen gamma' chain in hemostasis Blood 114 2009 3994 4001
226. A. Undas, J. Brozek, M. Jankowski, Z. Siudak, A. Szczeklik, and H. Jakubowski Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects Arterioscler. Thromb. Vasc. Biol. 26 2006 1397 1404 (Pubitemid 44305388)
227. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Blood 109 2007 2285 2292 (Pubitemid 46425865)
228. A. Undas, P. Podolec, K. Zawilska, M. Pieculewicz, I. Jedlinski, and E. Stepien Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke Stroke 40 2009 1499 1501
229. A. Undas, A. Slowik, P. Wolkow, A. Szczudlik, and W. Tracz Fibrin clot properties in acute ischemic stroke: relation to neurological deficit Thromb. Res. 125 2010 357 361
230. A. Undas, W.J. Sydor, K. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism Circulation 107 2003 17 20 (Pubitemid 36070925)
231. A. Undas, K. Szuldrzynski, E. Stepien, J. Zalewski, J. Godlewski, and W. Tracz Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress Atherosclerosis 196 2008 551 557
232. A. Undas, I. Wiek, E. Stepien, K. Zmudka, and W. Tracz Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome Diab. Care 31 2008 1590 1595
233. A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydlowska, A. Skubiszak, and K. Ciepluch Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 2009 4272 4278
234. M. Upmanyu, H.L. Wang, H.Y. Liang, and R. Mahajan Strain-dependent twist-stretch elasticity in chiral filaments J. R. Soc. Interface 5 2008 303 310
235. Z. Valnickova, and J.J. Enghild Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin J. Biol. Chem. 273 1998 27220 27224 (Pubitemid 28500432)
236. V.W. van Hinsbergh, and P. Koolwijk Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead Cardiovasc. Res. 78 2008 203 212 (Pubitemid 351556093)
237. D. Varon, and G. Spectre Antiplatelet agents Hematology. Am. Soc. Hematol. Educ. Program. 2009 267 272
238. G.A. Vehar, and E.W. Davie Preparation and properties of bovine factor VIII (antihemophilic factor) Biochemistry 19 1980 401 410 (Pubitemid 10103795)
239. Y.I. Veklich, O.V. Gorkun, L.V. Medved, W. Nieuwenhuizen, and J.W. Weisel Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization J. Biol. Chem. 268 1993 13577 13585 (Pubitemid 23307788)
240. C.J. Verkleij, M. Nieuwdorp, V.E. Gerdes, M. Morgelin, J.C. Meijers, and P.F. Marx The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor Thromb. Haemost. 102 2009 460 468
241. G.B. Villanueva, and N. Allen Acetylation of antithrombin III by aspirin Semin. Thromb. Hemost. 12 1986 213 215 (Pubitemid 17198754)
242. F.J. Walker Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation J. Biol. Chem. 256 1981 11128 11131 (Pubitemid 12181593)
243. U. Wartiovaara, M. Perola, H. Mikkola, K. Totterman, V. Savolainen, and A. Penttila Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males Atherosclerosis 142 1999 295 300 (Pubitemid 29059487)
244. C. Watala, and K. Gwozdzinski Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes Biochem. Pharmacol. 45 1993 1343 1349 (Pubitemid 23098333)
245. G.C. Webb, M. Coggan, A. Ichinose, and P.G. Board Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus Hum. Genet. 81 1989 157 160 (Pubitemid 19039861)
246. J.W. Weisel The mechanical properties of fibrin for basic scientists and clinicians Biophys. Chem. 112 2004 267 276 (Pubitemid 39574429)
247. J.W. Weisel Fibrinogen and fibrin Adv. Protein Chem. 70 2005 247 299 (Pubitemid 40544785)
248. J.W. Weisel Biophysics. Enigmas of blood clot elasticity Science 320 2008 456 457 (Pubitemid 351590652)
249. J.W. Weisel, C.W. Francis, C. Nagaswami, and V.J. Marder Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments J. Biol. Chem. 268 1993 26618 26624
250. J.W. Weisel, and L. Medved The structure and function of the alpha C domains of fibrinogen Ann. NY Acad. Sci. 936 2001 312 327 (Pubitemid 32613916)
251. J.W. Weisel, and C. Nagaswami Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled Biophys. J. 63 1992 111 128
252. J.W. Weisel, C. Nagaswami, and L. Makowski Twisting of fibrin fibers limits their radial growth Proc. Natl. Acad. Sci. USA 84 1987 8991 8995
253. M.S. Weiss, H.J. Metzner, and R. Hilgenfeld Two non-proline cis peptide bonds may be important for factor XIII function FEBS Lett. 423 1998 291 296 (Pubitemid 28129352)
254. R.W. Werling, L.R. Zacharski, W. Kisiel, S.P. Bajaj, V.A. Memoli, and S.M. Rousseau Distribution of tissue factor pathway inhibitor in normal and malignant human tissues Thromb. Haemost. 69 1993 366 369 (Pubitemid 23103124)
255. A.S. Wolberg, D.M. Monroe, H.R. Roberts, and M. Hoffman Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk Blood 101 2003 3008 3013 (Pubitemid 36857988)
256. C. Wolfenstein-Todel, and M.W. Mosesson Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma') Biochemistry 20 1981 6146 6149 (Pubitemid 12217934)
257. T.C. Wun, K.K. Kretzmer, T.J. Girard, J.P. Miletich, and G.J. Broze Jr. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains J. Biol. Chem. 263 1988 6001 6004
258. A.S. Xu, Y. Ohba, L. Vida, R.J. Labotka, and R.E. London Aspirin acetylation of betaLys-82 of human hemoglobin. NMR study of acetylated hemoglobin Tsurumai Biochem. Pharmacol. 60 2000 917 922
259. Z. Yang, J.M. Kollman, L. Pandi, and R.F. Doolittle Crystal structure of native chicken fibrinogen at 2.7 A resolution Biochemistry 40 2001 12515 12523 (Pubitemid 32979704)
260. Z. Yang, I. Mochalkin, and R.F. Doolittle A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides Proc. Natl. Acad. Sci. USA 97 2000 14156 14161 (Pubitemid 32016546)
261. Z. Yang, I. Mochalkin, L. Veerapandian, M. Riley, and R.F. Doolittle Crystal structure of native chicken fibrinogen at 5.5-A resolution Proc. Natl. Acad. Sci. USA 97 2000 3907 3912 (Pubitemid 30226060)
262. V.C. Yee, L.C. Pedersen, I. Le Trong, P.D. Bishop, R.E. Stenkamp, and D.C. Teller Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII Proc. Natl. Acad. Sci. USA 91 1994 7296 7300 (Pubitemid 24226850)
263. H. Yorifuji, K. Anderson, G.W. Lynch, L. Van de Water, and J. McDonagh B protein of factor XIII: differentiation between free B and complexed B Blood 72 1988 1645 1650 (Pubitemid 18268648)
264. S. Yu, B. Sher, B. Kudryk, and C.M. Redman Fibrinogen precursors. Order of assembly of fibrinogen chains J. Biol. Chem. 259 1984 10574 10581 (Pubitemid 14064160)
265. F. Zito, A. Di Castelnuovo, C. Amore, A. D'Orazio, M.B. Donati, and L. Iacoviello Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A casecontrol study in a sample of GISSI-2 patients Arterioscler. Thromb. Vasc. Biol. 17 1997 3489 3494 (Pubitemid 28028560)